Contents

Current Clinical Pharmacology, Volume 5 - Number 2

Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas

, 5(2): 74 - 81

Luca Arcaini and Raffaele Bruno


DOI: 10.2174/157488410791110751




Intraperitoneal Drug Therapy: An Advantage

, 5(2): 82 - 88

Kunal Chaudhary, Shadi Haddadin, Ravi Nistala and Chris Papageorgio


DOI: 10.2174/157488410791110779




The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade

, 5(2): 89 - 95

Steven G. Chrysant, George S. Chrysant, Catherine Chrysant and Mohammad Shiraz


DOI: 10.2174/157488410791110742




Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

, 5(2): 96 - 114

Veronique Dartois and Clifton E. Barry


DOI: 10.2174/157488410791110797




A Review of Clinical Pharmacokinetics and Pharmacodynamics of Galantamine, a Reversible Acetylcholinesterase Inhibitor for the Treatment of Alzheimer s Disease, in Healthy Subjects and Patients

, 5(2): 115 - 124

Fenglei Huang and Yali Fu


DOI: 10.2174/157488410791110805




Pretreatment by Hyperoxia - A Tool to Reduce Ischaemia-Reperfusion Injury in the Myocardium

, 5(2): 125 - 132

Inga Karu, Peeter Tahepold, Arno Ruusalepp and Joel Starkopf


DOI: 10.2174/157488410791110788




Pharmacotherapy of Mixed Dyslipidemia in the Metabolic Syndrome

, 5(2): 133 - 139

Kei Nakajima


DOI: 10.2174/157488410791110760




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science